No Small Cell Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) III-IV Phase non small cell lung cancers which were dignosised by pathology or cytology; (2) Efficacy evaluation were SD or up after chemotherapy and move to the Phase of maintenance treatment. The patient should be enter the group with one month after chemotherapy finished; (3) ECOG 0-3 or KPS>=50; (4) prediction survival time>=3 months; (5) Aged 18-75 years; (6) Sign the informed consent form,and has good compliance.
Exclusion criteria
Exclusion criteria: (1) Non small cell lung cancers which were not dignosised by pathology or cytology; (2) The pregnant women and lactation period women, psychotic patients; (3) The patient with serious uncontroled organic disease,such as function decompensated of herat, lung, liver, kidney; (4) Under other trials; (5) Allergic to the research medicine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor Size;OS;TTP;QoL;immune function;syptom; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor Marker; | — |
Countries
China
Contacts
Guang'anmen Hospital, China Academy of Chinese Medical Sciences